$IBIO Recent News Hazmat-suit maker’s shares jump on

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 11:03 PM

$IBIO Recent News

Hazmat-suit maker’s shares jump on Ebola orders 11:49 a.m. Oct. 30, 2014 - Russ Britt
IBio shares jump 15% in premarket trade 7:01 a.m. Oct. 24, 2014 - Tomi Kilgore
Fighting Ebola though investing: one firm’s approach 5:43 p.m. Oct. 21, 2014 - Wallace Witkowski
IBio shares tumble 24% in premarket trade 7:17 a.m. Oct. 20, 2014 - Tomi Kilgore
The danger of giving into market tantrums, and a messy Apple chart 7:46 a.m. Oct. 17, 2014 - Barbara Kollmeyer
Google, AMD shares drop as earnings miss 5:23 p.m. Oct. 16, 2014 - Wallace Witkowski
Sarepta says its Ebola drug has no ill effects 4:28 p.m. Oct. 16, 2014 - Russ Britt
Two biotechs staking claim in fight against Ebola 3:06 p.m. Oct. 16, 2014 - Russ Britt
IBio shares surge after company responds to inquiries regarding Ebola outbreak 7:52 a.m. Oct. 16, 2014 - Tomi Kilgore
IBio shares jump 33% in premarket trade 7:38 a.m. Oct. 16, 2014 - Tomi Kilgore
IBio offered to assist U.S. gov't in dealing with Ebola virus outbreak 7:37 a.m. Oct. 16, 2014 - Tomi Kilgore
AMD shares drop after hours 5:51 p.m. Oct. 13, 2014 - Wallace Witkowski
Fight against Ebola spreads to other nations 3:42 p.m. Oct. 13, 2014 - Russ Britt
Ebola stocks: 2 to sell, and 5 to consider buying 11:09 a.m. Oct. 13, 2014 - The Trading Deck
Stocks teeter on a key trend line as earnings pile up 7:19 a.m. Oct. 13, 2014 - Shawn Langlois
Ebola-related shares rally in premarket as Texas nurse tests positive 6:47 a.m. Oct. 13, 2014 - Ciara Linnane
Drug indexes split; Xoma in spotlight 11:01 a.m. Jan. 4, 2011 - Val Brickates Kennedy

10-Q: IBIO, INC. 4:11 p.m. Today - Edgar Online - (EDG = 10Q, 10K)
Fear In The Time Of Ebola Stocks: Debunking The iBio Bear Thesis 4:09 p.m. Nov. 4, 2014 - Seeking Alpha
Novavax Surges 10% on Ebola Vaccine Trial 4:38 a.m. Oct. 27, 2014 - InvestorPlace.com
Ebola in New York: iBio Inc. and Lakeland Industries Inc. Entice Speculators 6:22 a.m. Oct. 24, 2014 - InvestorPlace.com
iBio: A Wannabe Ebola Player Infecting Buyers With False Hope 12:24 p.m. Oct. 23, 2014 - Seeking Alpha
A Look at Oil Refiners, Ebola Fighters 8:14 a.m. Oct. 23, 2014 - Barrons.com
IBio (IBIO) Is Today's Dead Cat Bounce Stock 9:49 a.m. Oct. 22, 2014 - TheStreet.com
5 Ebola Stocks Making Massive Moves 8:03 a.m. Oct. 22, 2014 - InvestorPlace.com
5 Ebola Stocks Making Massive Moves 8:03 a.m. Oct. 22, 2014 - InvestorPlace.com
IBIO Role In Ebola Response Illustrates Company Strength 8:04 a.m. Oct. 21, 2014 - Seeking Alpha
Marginal Increases In Availability Of Borrows On GoPro 6:53 a.m. Oct. 21, 2014 - Seeking Alpha
Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear 6:10 a.m. Oct. 21, 2014 - TheStreet.com
Why iBio (IBIO) Stock Is Plummeting Today 10:45 a.m. Oct. 20, 2014 - TheStreet.com
Ibio Stock Cratering as Ebola Speculative Bubble Bursts 9:18 a.m. Oct. 20, 2014 - InvestorPlace.com
The Truth About iBio's Role In Ebola Drug Production 8:24 a.m. Oct. 20, 2014 - Seeking Alpha
Stomach-Churning Ride for Ebola Stocks 2:52 p.m. Oct. 17, 2014 - FOXBusiness
Why iBio (IBIO) Stock Continues to Soar Today 10:33 a.m. Oct. 17, 2014 - TheStreet.com
IBio (IBIO) Strong On High Relative Volume Today 10:00 a.m. Oct. 16, 2014 - TheStreet.com
Why iBio (IBIO) Stock Is Soaring Today 9:58 a.m. Oct. 16, 2014 - TheStreet.com
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Today - PR Newswire - PRF
Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO 2:36 p.m. Nov. 13, 2014 - GlobeNewswire
IBIO SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO 12:28 p.m. Nov. 12, 2014 - GlobeNewswire
SECURITIES ALERT: Rosen Law Firm Reminds iBio, Inc. Investors of Important Deadline in Class Action Filed by the Firm - IBIO 10:34 a.m. Nov. 11, 2014 - GlobeNewswire
Hagens Berman Reminds Investors of the Upcoming Lead Plaintiff Deadline of December 23, 2014 in the Class Action Lawsuit Against iBio, Inc. (NYSE MKT: IBIO) 8:30 a.m. Nov. 11, 2014 - GlobeNewswire
iBio Grants Caliber License for Production of Antibodies Targeting Ebola 8:31 a.m. Nov. 10, 2014 - Marketwired
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO 3:16 p.m. Oct. 31, 2014 - GlobeNewswire
Robbins Arroyo LLP: iBio, Inc. (IBIO) Misled Shareholders According to a Recently Filed Class Action 6:27 p.m. Oct. 29, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in iBio, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- IBIO 1:58 p.m. Oct. 29, 2014 - GlobeNewswire
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO 11:46 a.m. Oct. 29, 2014 - GlobeNewswire
Harwood Feffer LLP Announces Investigation of iBio, Inc. 8:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
Hagens Berman Notifies Investors That a Class Action With a Lead Plaintiff Deadline of December 23, 2014 Has Been Filed Against iBio, Inc. (NYSE MKT: IBIO) 8:30 a.m. Oct. 28, 2014 - GlobeNewswire
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against iBio, Inc. -- IBIO 7:30 p.m. Oct. 27, 2014 - GlobeNewswire
EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against iBio, Inc. -- IBIO 10:30 p.m. Oct. 24, 2014 - GlobeNewswire
The Rosen Law Firm Announces Investigation of Securities Fraud Claims Against iBio, Inc. – IBIO 5:21 p.m. Oct. 23, 2014 - BusinessWire - BZX
iBio Expands Exclusive Product Collaboration With Novici Biotech 8:32 a.m. Oct. 22, 2014 - Marketwired
iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak 8:31 a.m. Oct. 16, 2014 - Marketwired
iBio Reports on Filing of 2014 Annual Report 5:00 p.m. Oct. 3, 2014 - Marketwire
Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board 8:32 a.m. Sept. 2, 2014 - Marketwire
iBio Receives European Patent Allowances for Protein Expression Technology 8:31 a.m. Aug. 28, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...